Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of intertrigo: zinc oxide in ketoconazole cream with or without hydrocortisone substitution
2006-006234-18Phase 3Active
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of zinc oxide + ketoconazole + hydrocortisone in intertrigo (2 arms), sponsored by Medisch Centrum Leeuwarden. Primary endpoint: Reduction of intertrigo area. Started Feb 2007; status: active.
02
Drugs
zinc oxide + ketoconazole + hydrocortisone
03
Conditions
intertrigo
Beyond the preview
Go deeper on 2006-006234-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006234-18.